Mesquita MA et al. |
One-week dual therapy with ranitidine bismuth citrate and clarithromycin for the treatment of Helicobacter pylori infection in Brazilian patients with peptic ulcer. |
2005 |
World J. Gastroenterol. |
pmid:15962376
|
Keshavarz AA et al. |
Omeprazole-based triple therapy with low-versus high-dose of clarithromycin plus amoxicillin for H pylori eradication in Iranian population. |
2007 |
World J. Gastroenterol. |
pmid:17352026
|
Losurdo G et al. |
Role of concomitant therapy for eradication: A technical note. |
2016 |
World J. Gastroenterol. |
pmid:27784977
|
Robles-Jara C et al. |
Is a 7-day Helicobater pylori treatment enough for eradication and inactivation of gastric inflammatory activity? |
2008 |
World J. Gastroenterol. |
pmid:18473407
|
Koussoulas V et al. |
Evidence for the role of gastric mucosa at the secretion of soluble triggering receptor expressed on myeloid cells (strem-1) in peptic ulcer disease. |
2007 |
World J. Gastroenterol. |
pmid:17729416
|
Lin LC et al. |
Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials. |
2016 |
World J. Gastroenterol. |
pmid:27340362
|
Miehlke S et al. |
Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study). |
2001 |
World J. Gastroenterol. |
pmid:11819768
|
Iannone A et al. |
New fecal test for non-invasive detection: A diagnostic accuracy study. |
2018 |
World J. Gastroenterol. |
pmid:30038469
|
Lee HJ et al. |
Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies. |
2015 |
World J. Gastroenterol. |
pmid:25574111
|
Brennan DE et al. |
Can bacterial virulence factors predict antibiotic resistant infection? |
2018 |
World J. Gastroenterol. |
pmid:29531461
|
Buzás GM and Józan J |
First-line eradication of H pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2004. |
2006 |
World J. Gastroenterol. |
pmid:16981260
|
Sargýn M et al. |
Type 2 diabetes mellitus affects eradication rate of Helicobacter pylori. |
2003 |
World J. Gastroenterol. |
pmid:12717872
|
Lai YC et al. |
Pre-treatment urea breath test results predict the efficacy of Helicobacter pylori eradication therapy in patients with active duodenal ulcers. |
2004 |
World J. Gastroenterol. |
pmid:15052680
|
Zhou Q et al. |
Drug utilization of clarithromycin for gastrointestinal disease treatment. |
2008 |
World J. Gastroenterol. |
pmid:18932287
|
Isomoto H et al. |
Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin. |
2005 |
World J. Gastroenterol. |
pmid:15786539
|
Shimbo I et al. |
Effect of Clostridium butyricum on fecal flora in Helicobacter pylori eradication therapy. |
2005 |
World J. Gastroenterol. |
pmid:16437727
|
Bustamante-Rengifo JA et al. |
Effect of treatment failure on the CagA EPIYA motif in strains from Colombian subjects. |
2017 |
World J. Gastroenterol. |
pmid:28373764
|
Chen KY et al. |
Hybrid vs sequential therapy for eradication of Helicobacter pylori in Taiwan: A prospective randomized trial. |
2015 |
World J. Gastroenterol. |
pmid:26420970
|
Hwang JJ et al. |
Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradication. |
2015 |
World J. Gastroenterol. |
pmid:26401089
|
Garza-González E et al. |
A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication. |
2014 |
World J. Gastroenterol. |
pmid:24587620
|